Asset Management Resources’s iShares Biotechnology ETF IBB Stock Holding History

Asset Management Resources’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$209K	Buy	+1,540	New	+$188K	0.12%	57

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Asset Management Resources's IBB Position: Q4 2023 in Review

Asset Management Resources opened a new position in iShares Biotechnology ETF (IBB) in Q4 2023: 1,540 shares worth $209K. The stake represents 0.12% of the portfolio and ranks #57 among its holdings.

872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

Asset Management Resources held 1,540 shares of iShares Biotechnology ETF worth $209K as of Q4 2023.
iShares Biotechnology ETF was a new Asset Management Resources position in Q4 2023.
iShares Biotechnology ETF made up 0.12% of Asset Management Resources's portfolio in Q4 2023, its #57 holding.
872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on Asset Management Resources's 13F filing for Q4 2023, filed 25 Jan 2024.